NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Partnerships for Health, Wealth and Innovation > Concerns raised as opioid prescriptions rise across UK

Concerns raised as opioid prescriptions rise across UK

21 December 2018 · Listed under Partnerships for Health, Wealth and Innovation, Translational Data Science

Researchers supported by the NIHR Oxford Biomedical Research Centre(BRC) have recommended greater action to promote best practice, as a new study revealed a rise in prescriptions of opioids for treating chronic pain over thepast 20 years.

The research reviewing opioid prescribing, published in the Lancet Psychiatry, showed that UK doctors are prescribing more and stronger opioid drugs to patients: there was a 34% rise between 1998 and 2016, which, when corrected for total oral morphine equivalency, increased to 127%.

Credit – Kurtis Garbutt via Flickr

However, the study also showed a decline in prescriptions between 2016 and 2017.

The research revealed a wide variation in opioid prescribing across the country, with the highest prescribers in northern and coastal areas and the lowest in Greater London. Larger practice list size, rural location and deprivation are all also associated with greater high-dose prescribing rates.

Ben Goldacre, Senior Clinical Research Fellow from Oxford University’s Nuffield Department of Primary Care Health Sciences, who led the study, said: “The US is in the middle of an opioid crisis. UK use has not yet matched that scale, but our work shows that close monitoring is needed.

“This is why we have shared all our tools on OpenPrescribing.net. Our website is open to all, allowing clinicians and others to see what individual practices and regions are prescribing. High prescribers are not necessarily bad prescribers: they may, for example, specialise in treating substance misuse. But thoughtful data monitoring is key, to ensure problems are not missed.

“Taking greater action to promote best practice, such as prescribing lower doses for a shorter duration, could also save substantial NHS resources. If every practice changed their prescribing of high-dose opioids to match practices at the lowest 10%, this could save 543,000 high-dose prescriptions over six months.”

The study – based on all prescribing data in the NHS from 1998-2018 – is the largest and most comprehensive opioid trends study to date, and is accompanied by a live tool for anyone to check the latest info on their practice or CCG.

The study and tool were created by the DataLab at the University of Oxford, which is headed by Dr Ben Goldacre. The DataLab is a multidisciplinary team of clinicians, academics and software engineers: they build interactive data-driven tools for the NHS and academia, as well as pure academic papers.

As well as Oxford BRC, the study was funded by the NIHR School of Primary Care Research and NHS England.

← Genetic changes associated with physical activity emerge thanks to machine learning pioneers
Does general practice get a bad press? →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre